Arthritis Consumer Experts

Arthritis Consumer Experts JointHealth™—a trusted source for information on arthritis, treatments, research and health policy.

In this episode of Arthritis At Home, we are sharing the   interview with Dr. Deborah Marshall, Professor at the Cu***ng...
11/13/2025

In this episode of Arthritis At Home, we are sharing the interview with Dr. Deborah Marshall, Professor at the Cu***ng School of Medicine in the Department of Community Health Sciences at the University of Calgary.

Ellen Wang, ACE’s Programs Coordinator, speaks with Dr. Marshall about some of the findings from the Ucan Can-Du and Cure International prospective study that tracks the impacts of juvenile idiopathic arthritis (JIA) on employment, usual activities and out-of-pocket costs.

Watch now: https://arthritisathome.jointhealth.org/?p=6600

---------

Dans cette capsule de « À la maison avec l’arthrite », nous partageons avec vous l’entrevue menée auprès de la Dre Deborah Marshall, professeure de sciences de la santé communautaire à la Faculté de médecine Cu***ng de l’Université de Calgary.

Ellen Wang, coordonnatrice des programmes auprès du comité ACE, s’entretient avec la Dre Marshall au sujet de certaines conclusions tirées de l’étude prospective menée par Ucan Can-Du et Cure International, qui examine les répercussions de l’arthrite juvénile idiopathique (AJI) sur l’emploi, les activités courantes et les frais à la charge des patients.

Visionner maintenant : https://arthritisathome.jointhealth.org/?p=6601&lang=fr



University of Calgary's Cu***ng School of Medicine
Arthritis Research Canada
Arthritis Broadcast Network
Arthritis Society Canada
Cassie + Friends Society

Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organiza...
11/11/2025

Canada’s Drug Agency (CDA-AMC) is currently welcoming patients and their caregivers to provide input to patient organizations on the manufacturer’s submission for roflumilast (Zoryve®) for plaque psoriasis.

If you live with plaque psoriasis with or care for someone with plaque psoriasis with, please send us your input by November 21, 2025. Your input will be anonymous.

Please contact us at feedback@jointhealth.org to provide your input.

Learn more: https://bit.ly/JHECDAPatientInput_roflumilastforplaquepsoriasisEN

---------

L’Agence des médicaments du Canada (CDA-AMC) invite actuellement les patients et leurs fournisseurs de soins à faire parvenir aux organismes représentant les patients leurs suggestions et commentaires sur la présentation par le fabricant du roflumilast (Zoryve®) pour le traitement du psoriasis en plaques.

Si vous êtes atteint de psoriasis en plaques ou prodiguez des soins à quelqu’un qui en souffre, n’hésitez pas à nous faire parvenir vos commentaires d’ici le 21 novembre 2025. Vos commentaires demeureront anonymes.

Veuillez communiquer avec nous à feedback@jointhealth.org pour fournir vos commentaires.

Apprendre encore plus : https://bit.ly/JHECDAPatientInput_roflumilastforplaquepsoriasisFR



Arthritis Research Canada
Arthritis Society Canada
Psoriasis Canada
Canadian Spondyloarthritis Association

What good is a breakthrough medication if you can’t afford it? Patent manipulation can keep medication prices artificial...
11/10/2025

What good is a breakthrough medication if you can’t afford it? Patent manipulation can keep medication prices artificially high. For patients who can’t afford them, high costs force many to skip or ration their medication.

Learn more: https://advocacy.jointhealth.org/patients-and-patents/

Do you have joint  ? The Talk to Your Doctor About Joint Pain Handout aims to improve the quality of life for people wit...
11/07/2025

Do you have joint ?

The Talk to Your Doctor About Joint Pain Handout aims to improve the quality of life for people with arthritis, including their physical activity, sleep, mental health, relationships & work life.

Download here:https://jointhealth.org/pdfs/TalkDoctoraboutJointPainHandoutEN.pdf

In this  , we are sharing the   interview with Dr. Tommy Gerschman, a pediatric rheumatologist based in North Vancouver,...
11/06/2025

In this , we are sharing the interview with Dr. Tommy Gerschman, a pediatric rheumatologist based in North Vancouver, British Columbia, on artificial intelligence (AI) scribing and sports medicine in juvenile idiopathic arthritis.

Watch now: https://arthritisathome.jointhealth.org/?p=6589

---------

Dans cette capsule de « À la maison avec l’arthrite », nous partageons avec vous l’entrevue menée auprès du Dr Tommy Gerschman, rhumatologue pédiatrique exerçant à North Vancouver, en Colombie-Britannique, portant sur la transcription assistée par intelligence artificielle (IA) et la médecine sportive dans le cas de l’arthrite juvénile idiopathique.

Visionner maintenant : https://arthritisathome.jointhealth.org/?p=6590&lang=fr



University of British Columbia
Arthritis Society Canada
Arthritis Research Canada
Cassie + Friends Society

Upadacitinib (Rinvoq®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare p...
11/05/2025

Upadacitinib (Rinvoq®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out a questionnaire on a website called Your Voice, you can provide feedback about Rinvoq® for the treatment of giant cell arteritis.

You can give input if you are a B.C. resident and have giant cell arteritis, a caregiver to someone with giant cell arteritis, or if your group represents people who live with giant cell arteritis.

If you would like our help in providing your input, you can email your comments to feedback@jointhealth.org. Please provide your input to us by Friday, November 21, 2025 so that we may submit the questionnaire in time for the deadline.

Learn more: https://bit.ly/JHEBCYourVoice_upadacitinibforGCA



Arthritis Society Canada
Arthritis Research Canada
Fraser Health
Providence Health Care
Island Health
University of British Columbia

Roflumilast cream (Zoryve®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaC...
11/04/2025

Roflumilast cream (Zoryve®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out a questionnaire on a website called Your Voice, you can provide feedback about Zoryve® for the treatment of atopic dermatitis in patients 6 years of age and older.

The submission deadline is November 25, 2025. Patients and caregivers may give their input directly through the link below or by emailing us at feedback@jointhealth.org

Learn more and submit your patient input here: https://bit.ly/JHEBCYourVoice_roflumilastforAD



Arthritis Society Canada
Arthritis Research Canada
Fraser Health
University of British Columbia
Providence Health Care

It’s National Pain Awareness Week. Did you know pain's direct and indirect cost in Canada is $40.3B per year? Implementi...
11/03/2025

It’s National Pain Awareness Week. Did you know pain's direct and indirect cost in Canada is $40.3B per year? Implementing Government of Canada's Action Plan for Pain in Canada can reduce the human and financial toll of pain. Track its progress here: https://actionplan.paincanada.ca/

All forms of arthritis are associated with pain, particularly when they are not well managed. Depending on disease type and severity, arthritis pain can range from mild and irritating to excruciating. Arthritis-related pain and disability affect many aspects of life including daily activities, leisure, labour force participation, and social activities. In fact, for people living with arthritis, the number one reason for loss of joint mobility and function is chronic or episodic pain.



Pain Canada
Arthritis Society Canada
Pain BC
Arthritis Research Canada

Happy Birthday to Cheryl Koehn, ACE's President and Founder! 🥳 We hope you will have a relaxing day like Molly, the ACE ...
11/01/2025

Happy Birthday to Cheryl Koehn, ACE's President and Founder! 🥳 We hope you will have a relaxing day like Molly, the ACE Mascot.

Thank you for being a trailblazer and your continued support for those living with all forms of .

In this special episode of  , host Kelly Lendvoy speaks with Cheryl Koehn, President and Founder of Arthritis Consumer E...
10/30/2025

In this special episode of , host Kelly Lendvoy speaks with Cheryl Koehn, President and Founder of Arthritis Consumer Experts, about the release of the 2025 ACE Arthritis Medications Report Card and key changes in this year’s rankings – including new listings and major shifts among provinces.

The Report Card is one of the Canadian arthritis community’s most trusted advocacy tools, ranking each provincial, territorial, and federal drug plan on how well they provide reimbursement coverage for arthritis medications – including biologics, biosimilars, and targeted synthetic molecule therapies.

Watch now: https://arthritisathome.jointhealth.org/?p=6576

--------

Dans cette capsule spéciale de « À la maison avec l’arthrite », notre hôte Kelly Lendvoy s’entretient avec Cheryl Koehn, présidente et fondatrice du comité ACE (Arthritis Consumer Experts), au sujet de la publication de sa Fiche-rapport 2025 sur les médicaments contre l’arthrite et des changements majeurs dans le classement de cette année, notamment en ce qui a trait aux nouvelles inscriptions et aux changements importants entre les provinces.

Cette Fiche-rapport est l’un des outils les plus fiables au service de la défense des intérêts de la collectivité canadienne des personnes atteintes d’arthrite. Elle classe chaque régime d’assurance-médicaments provincial, territorial et fédéral en fonction de la qualité de la couverture de remboursement des médicaments contre l’arthrite, y compris les médicaments biologiques, les biosimilaires et les thérapies ciblées à molécules synthétiques.

Visionner maintenant : https://arthritisathome.jointhealth.org/?p=6578&lang=fr



Arthritis Research Canada
Arthritis Society Canada
Canadian Rheumatology Association
Canadian Spondyloarthritis Association
Lupus Canada
Cassie + Friends Society
Canadian Arthritis Patient Alliance
Scleroderma Canada
Psoriasis Canada

Today is World Psoriasis Day!In this  , Dr. Lihi Eder talks about the connection between psoriasis and psoriatic arthrit...
10/29/2025

Today is World Psoriasis Day!

In this , Dr. Lihi Eder talks about the connection between psoriasis and psoriatic arthritis. She also talks about how we can work towards prevention.

Watch now: https://arthritisathome.jointhealth.org/?p=5450

Address

#210/1529 West 6th Avenue
Vancouver, BC
V6J1R1

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16049741366

Alerts

Be the first to know and let us send you an email when Arthritis Consumer Experts posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram